Author:
Porta-Sánchez Andreu,Mazzanti Andrea,Tarifa Carmen,Kukavica Deni,Trancuccio Alessandro,Mohsin Muhammad,Zanfrini Elisa,Perota Andrea,Duchi Roberto,Hernandez-Lopez Kevin,Jáuregui-Abularach Miguel Eduardo,Pergola Valerio,Fernandez Eugenio,Bongianino Rossana,Tavazzani Elisa,Gambelli Patrick,Memmi Mirella,Scacchi Simone,Pavarino Luca F.,Franzone Piero Colli,Lentini Giovanni,Filgueiras-Rama David,Galli Cesare,Santiago Demetrio Julián,Priori Silvia G.
Abstract
AbstractTimothy syndrome 1 (TS1) is a multi-organ form of long QT syndrome associated with life-threatening cardiac arrhythmias, the organ-level dynamics of which remain unclear. In this study, we developed and characterized a novel porcine model of TS1 carrying the causative p.Gly406Arg mutation in CACNA1C, known to impair CaV1.2 channel inactivation. Our model fully recapitulated the human disease with prolonged QT interval and arrhythmic mortality. Electroanatomical mapping revealed the presence of a functional substrate vulnerable to reentry, stemming from an unforeseen constitutional slowing of cardiac activation. This signature substrate of TS1 was reliably identified using the reentry vulnerability index, which, we further demonstrate, can be used as a benchmark for assessing treatment efficacy, as shown by testing of multiple clinical and preclinical anti-arrhythmic compounds. Notably, in vitro experiments showed that TS1 cardiomyocytes display Ca2+ overload and decreased peak INa current, providing a rationale for the arrhythmogenic slowing of impulse propagation in vivo.
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Splawski, I. et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004).
2. Cohen-Kutner, M. et al. Calcineurin controls voltage-dependent-inactivation (VDI) of the normal and Timothy cardiac channels. Sci. Rep. 2, 1–10 (2012).
3. Dick, I. E., Joshi-Mukherjee, R., Yang, W. & Yue, D. T. Arrhythmogenesis in Timothy syndrome is associated with defects in Ca2+-dependent inactivation. Nat. Commun. 7, 10370 (2016).
4. Gao, Y. et al. Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in Timothy syndrome. Circ. Arrhythm. Electrophysiol. 6, 614–622 (2013).
5. Sicouri, S. et al. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. Heart Rhythm 4, 638–647 (2007).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献